Lv11
70 积分 2025-05-08 加入
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
3个月前
已完结
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803
3个月前
已完结
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803
3个月前
已关闭
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
3个月前
已完结
The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer
3个月前
已完结
Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers
3个月前
已完结
Mutation in BRAF V600E: A Poor Prognostic Marker in Stage III Colon Cancers With Deficient MMR?
3个月前
已完结
Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer
3个月前
已完结
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial
3个月前
已完结
Impact of BRAF Gene Mutation in Nonmetastatic Colorectal Cancer on Disease Progression and Survival Outcomes
3个月前
已完结
皖公网安备34019202002308
